| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/18/2002 | EP1240326A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/18/2002 | EP1240313A2 Homologues of human heparanase and splice variants thereof |
| 09/18/2002 | EP1240310A2 Method of inactivating microorganisms |
| 09/18/2002 | EP1240202A2 Inhibitors of complement activation, their preparation and use |
| 09/18/2002 | EP1240197A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1240195A2 Polynucleotides and polypeptides encoded thereby |
| 09/18/2002 | EP1240194A2 Novel human protein kinases and protein kinase-like enzymes |
| 09/18/2002 | EP1240193A2 Peptide fragments of colostrinin |
| 09/18/2002 | EP1240192A2 Attenuated microorganisms for the treatment of infection |
| 09/18/2002 | EP1240191A1 P. gingivalis antigenic composition |
| 09/18/2002 | EP1240189A2 Hepatitis virus sentinel virus i (svi) |
| 09/18/2002 | EP1240186A2 Improvements in or relating to immune responses to hiv |
| 09/18/2002 | EP1240182A2 Daptomycin analogs and their use as antibacterial agents |
| 09/18/2002 | EP1240181A2 Daptomycin analogs as antibacterial agents |
| 09/18/2002 | EP1240171A1 Cyclopenteneone derivatives |
| 09/18/2002 | EP1240164A1 Benzazole derivatives and their use as jnk modulators |
| 09/18/2002 | EP1240160A1 Substituted pyridazines having cytokine inhibitory activity |
| 09/18/2002 | EP1240153A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 09/18/2002 | EP1240148A1 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii |
| 09/18/2002 | EP1240133A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 09/18/2002 | EP1239923A2 Stabilized veterinary compositions comprising more than one antiviral agent |
| 09/18/2002 | EP1239876A1 Vaccine compositions |
| 09/18/2002 | EP1239872A2 Enzyme treatment for infection |
| 09/18/2002 | EP1239870A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1239868A2 Use of an immunosuppressant for increasing an antifungal activity of a lipopetide |
| 09/18/2002 | EP1239867A2 Methods for treating and preventing damage to mucosal tissue |
| 09/18/2002 | EP1239853A1 Fungicidal agent containing n-chlorotaurine and use thereof |
| 09/18/2002 | EP1239852A2 Bissulfonamide derivatives as enzyme inhibitors |
| 09/18/2002 | EP1239845A2 Hydroxide-releasing agents as skin permeation enhancers |
| 09/18/2002 | EP1239841A1 Pharmaceutical formulations comprising sodium amoxycilline and potassium clavulanate |
| 09/18/2002 | EP1239840A2 Antiviral medication |
| 09/18/2002 | EP1239831A1 Improved pharmaceutical compositions for poorly soluble drugs |
| 09/18/2002 | EP1239826A2 Cosmetic and/or pharmaceutical preparations |
| 09/18/2002 | EP1239791A1 Dental prosthesis with means for the release of active substances |
| 09/18/2002 | EP1095029B1 Piperazine derivatives inhibiting human immunodeficiency virus replication |
| 09/18/2002 | EP0975573B1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity |
| 09/18/2002 | EP0918742B1 Water-miscible esters of monoglycerides having antimicrobial activity |
| 09/18/2002 | EP0904285B1 Cyclic adhesion inhibitors |
| 09/18/2002 | EP0888322B1 Electrophilic ketones for the treatment of herpesvirus infections |
| 09/18/2002 | EP0874839B1 Furan- and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants |
| 09/18/2002 | EP0767793B1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 09/18/2002 | EP0724432B1 Methods and compositions for microencapsulation of antigens for use as vaccines |
| 09/18/2002 | EP0630249B1 Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof |
| 09/18/2002 | EP0614486B1 Targeted delivery of virus vector to mammalian cells |
| 09/18/2002 | CN1370238A Human poly(ADP-ribose) polymerase 2 materials and methods |
| 09/18/2002 | CN1370237A Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of non-essential gene |
| 09/18/2002 | CN1370232A Methods for making APO-2 ligand using divalent metal ions |
| 09/18/2002 | CN1370172A Optically active pyrrolopyridazine compound |
| 09/18/2002 | CN1370171A Process for preparing inhibitors of nucleoside metabolism |
| 09/18/2002 | CN1370170A DNA methyltransferase inhibitors |
| 09/18/2002 | CN1370159A Indole derivatives and their use for treatment of osteoporosis amongst other applications |
| 09/18/2002 | CN1370158A Fatty acid synthase inhibitors |
| 09/18/2002 | CN1370154A Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/18/2002 | CN1370147A Novel integrin alpha V\ beta3 inhibitors |
| 09/18/2002 | CN1370146A Alpha/Beta integrin inhibitors |
| 09/18/2002 | CN1370083A Ninovasive genetic immnization, expression products therefrom, and uses thereof |
| 09/18/2002 | CN1370078A Prion protein peptides and uses thereof |
| 09/18/2002 | CN1370074A Method of treating malignancies and viral infections and improving immune function with dietary supplement |
| 09/18/2002 | CN1370070A Carnitine analogues as topical, microbicidal spermicides |
| 09/18/2002 | CN1370068A Pharmaceutical agent comprising benzamide derivative as active ingredient |
| 09/18/2002 | CN1370064A synergistic antibacterial combination |
| 09/18/2002 | CN1369310A Coating agent for treating tinea and eczema |
| 09/18/2002 | CN1369307A Composite Chinese medicine for treating heptic fibrosis and cirrhosis due to hepatitis B and its mfg. method |
| 09/18/2002 | CN1369296A 'Jiwenning' for treating chicken pest and its preparing process |
| 09/18/2002 | CN1369291A Medicine for treating AIDS and its preparing process |
| 09/18/2002 | CN1369267A Medicinal composition containing zidovudine and bideoxyinosine |
| 09/18/2002 | CN1091109C Substd 2,4-diaminopyrimidines |
| 09/18/2002 | CN1090960C Process for preparing onychomycosis liquid |
| 09/18/2002 | CA2403648A1 Use of organophosphorous compounds for producing a medicament for treating infections |
| 09/17/2002 | US6452007 Crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine |
| 09/17/2002 | US6451994 Polypeptides, polynucleotides; drug screening; diagnosing alzheimer*s, parkinson*s, huntington*s, and creutzfelt-jacob disease; amyotrophic lateral sclerosis, cystic fibrosis |
| 09/17/2002 | US6451973 Human immunodeficiency virus (hiv) protease inhibitors |
| 09/17/2002 | US6451968 Hoogsteen type base pairing in triplex motif; diagnosis; heat resistance; detection of point mutations, restriction enzyme sites, and transcription inhibition |
| 09/17/2002 | US6451851 Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agent |
| 09/17/2002 | US6451839 Indole sPLA2 inhibitors |
| 09/17/2002 | US6451838 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/17/2002 | US6451822 3-(Amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of HIV related diseases |
| 09/17/2002 | US6451820 Substituted 1-(4-aminophenly)triazoles and their use as anti-inflammatory agents |
| 09/17/2002 | US6451811 Herpes virus |
| 09/17/2002 | US6451810 Amide substituted imidazoquinolines |
| 09/17/2002 | US6451804 Heteroalkylamino-substituted bicyclic nitrogen heterocycles |
| 09/17/2002 | US6451770 A liquid jet intradermal administration apparatus that administers an immunogenic composition or vaccine to an animal: without a needle, and into the epidermis, dermis and/or hypodermis; wherein the apparatus includes an |
| 09/17/2002 | US6451769 Compositions and methods for administering Borrelia DNA |
| 09/17/2002 | US6451768 Macrolide antiinfective agents |
| 09/17/2002 | US6451579 Regulated expression of recombinant proteins using RNA viruses |
| 09/17/2002 | US6451522 Combining agent to be tested, antibody or antigen-binding fragment which binds to amino terminal domain of mammalian cc-chemokine receptor 2, mammalian cc-chemokine receptor 2 or ligand-binding variant, measuring binding |
| 09/17/2002 | US6451323 Recombinant newcastle disease virus RNA expression systems and vaccines |
| 09/17/2002 | US6451322 Retrovirus like particles made non infectious by a plurality of mutations |
| 09/17/2002 | US6451321 Bird and poultry vaccine; side effect reduction of lesions |
| 09/17/2002 | US6451320 Combined hepatitis and herpesvirus antigen compositions |
| 09/17/2002 | US6451311 An antibody which binds procalcitonin but not free calcitonin, free katacalcin and free n-procalcitonin; used as an in vitro or in vivo diagnostic agent |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | US6451309 Prophylactic and therapeutic monoclonal antibodies |
| 09/17/2002 | US6451307 3′-exonuclease, production and use thereof |
| 09/17/2002 | US6451305 Methods for stimulating T cell responses to tumor cells expressing LFA-3 and a CD28 or CTLA4 ligand |
| 09/17/2002 | US6451286 Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds |
| 09/17/2002 | CA2365412C Orally administrable solid ribavirin dosage forms and process for making them |
| 09/17/2002 | CA2260007C Method for treating gastrointestinal damage |
| 09/17/2002 | CA2243459C Human antibodies that bind human tnf.alpha. |
| 09/17/2002 | CA2238640C Non-toxic mutants of pathogenic gram-negative bacteria |